Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2011
03/24/2011US20110070642 Device and method for isolating and cultivating live cells on a filter or extracting the genetic material thereof
03/24/2011US20110070641 Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
03/24/2011US20110070629 Method for micropropagation of monocots based on sustained totipotent cell cultures
03/24/2011US20110070623 Self-inactivating helper adenoviruses for the production of high-capactiy recombinant adenoviruses
03/24/2011US20110070615 Compositions and Methods Relating to Anti-IGF-1 Receptor Antibodies
03/24/2011US20110070613 Monoclonal Antibody
03/24/2011US20110070605 Reversible mhc multimer staining for functional purification of antigen-specific t cells
03/24/2011US20110070581 Separation of Leukocytes
03/24/2011US20110070313 Methods of inducing cell differentiation with placental extracts
03/24/2011US20110070280 Method for differentiating embryonic stem cells into cells expressing aqp-1
03/24/2011US20110070276 Bioactive keratin peptides
03/24/2011US20110070254 Mutations in the influenza a virus ns1 gene and use thereof
03/24/2011US20110070253 Tumour-associated peptides binding to mhc molecules
03/24/2011US20110070251 Cancer vaccine composition
03/24/2011US20110070250 Therapeutical Composition Containing Dentritic Cells and use Thereof
03/24/2011US20110070246 Antibodies Against CDCP1 for the Treatment of Cancer
03/24/2011US20110070243 Compositions and methods for the treatment of tumor of hematopoietic
03/24/2011US20110070239 Anti-ox40l antibodies
03/24/2011US20110070208 Hbv epitope reactive exogenous t cell receptor (tcr) and uses thereof
03/24/2011US20110070207 Therapeutic composition for atopic dermatitis
03/24/2011US20110070206 Methods of applying physical stimuli to cells
03/24/2011US20110070205 Multipotent stem cells and uses thereof
03/24/2011US20110070204 Medium for handling and storing biological tissues of the musculoskeletal system outside an organism
03/24/2011US20110070203 Mesendoderm and mesoderm cell populations
03/24/2011US20110070201 Mucosal or enteral administration of biologically active macromolecules
03/24/2011US20110070192 Method of preparation of novel nucleoside analogs and uses
03/24/2011US20110070191 T cell receptor fusions and conjugates and methods of use there of
03/24/2011US20110070190 Heterocyclic antiviral compounds
03/24/2011US20110070189 Heterocyclic antiviral compounds
03/24/2011US20110070164 Post release modification of viral envelopes
03/24/2011US20110070162 Rna interference mediating small rna molecules
03/24/2011US20110070154 Artificial cells
03/24/2011US20110070153 Artificial cells
03/24/2011CA2781519A1 Coiled coil and/or tether containing protein complexes and uses thereof
03/24/2011CA2774729A1 Antigen specific tolerogenic antigen presenting cells and related uses compositions, methods and systems
03/24/2011CA2774446A1 Hiv-1 antibodies
03/24/2011CA2774193A1 Novel method for producing differentiated cells
03/24/2011CA2772447A1 Steroidogenesis modified cells and methods for screening for endocrine disrupting chemicals
03/23/2011EP2299269A1 Protein fragment complementation assay based on beta-lactamase
03/23/2011EP2298927A2 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
03/23/2011EP2298924A2 Improved method for the recovery of non-segmented, negative-stranded RNA viruses from cDNA
03/23/2011EP2298918A2 Regulation of Plant Biomass and Stress Tolerance
03/23/2011EP2298904A1 Xylanases, nucleic acids encoding them and methods for making and using them
03/23/2011EP2298903A2 Alpha-amylase mutants with altered properties
03/23/2011EP2298902A1 Luciferase biosensor
03/23/2011EP2298899A2 CRSP proteins (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor
03/23/2011EP2298898A1 High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences
03/23/2011EP2298878A2 Compositions and methods for the diagnosis of cancer
03/23/2011EP2298873A1 Lipolytic enzyme variants
03/23/2011EP2298871A1 Phospholipases, nucleic acids encoding them and methods for making and using them
03/23/2011EP2298867A2 Method of controlling differentiation of embryonic stem (ES) cells by culturing ES cells in the presence of bmp-2 pathway antagonists
03/23/2011EP2298866A1 Artificial kidney precursor and process for production thereof
03/23/2011EP2298865A1 Blood platelet induction method
03/23/2011EP2298864A2 Mesenchymal stem cells and uses therefor
03/23/2011EP2298863A2 Mesenchymal stem cells and uses therefor
03/23/2011EP2298862A2 Mesenchymal stem cells and uses therefor
03/23/2011EP2298861A2 Mesenchymal stem cells and uses therefor
03/23/2011EP2298859A2 Genetically modified host cells and use of same for producing isoprenoid compounds
03/23/2011EP2298858A1 Bed material for cell culture, method for co-culture of cell and co-cultured cell sheet obtainable therefrom
03/23/2011EP2298816A2 Apoptosis induced by an antibody against Her2
03/23/2011EP2298815A1 B-cell reduction using CD37-specific and CD20-specific binding molecules
03/23/2011EP2298808A1 Anti-C5 antibodies and their therapeutic uses
03/23/2011EP2298806A1 Antibodies that bind cell-associated CA 125/0722P and methods of use thereof
03/23/2011EP2298804A2 Monoclonal antibody production by EBV transformation of B cells
03/23/2011EP2298803A2 Human G-protein coupled receptor and ligands thereof
03/23/2011EP2298802A1 T1R3 taste receptors and genes encoding same
03/23/2011EP2298793A2 Polypeptide fragments of hepatitis E virus, vaccine composition comprising said fragments and diagnostic kits
03/23/2011EP2298789A1 Mammalian genes; related reagents and methods
03/23/2011EP2298728A1 Transfection reagents
03/23/2011EP2298436A1 Tangential flow filtration devices and methods for leukocyte enrichment
03/23/2011EP2298357A1 Compositions and methods for regulated protein expression in gut
03/23/2011EP2298355A2 Albumin fusion proteins
03/23/2011EP2298346A2 Human antibodies specific to kdr and uses thereof
03/23/2011EP2298343A1 Composition and method for increasing cell density in cell cultures infected with lentivirus
03/23/2011EP2298334A2 Tweak receptor
03/23/2011EP2298333A2 Tweak receptor
03/23/2011EP2298301A2 Medicaments for increasing endogenous Erythropoietin (EPO)
03/23/2011EP2298231A2 Apparatus and methods for providing sex-sorted animal sperm
03/23/2011EP2298067A1 Novel pesticidal toxins
03/23/2011EP2297576A1 Established human brown adipocyte line and method for differentiation from an hmads cell line
03/23/2011EP2297319A1 Growth factors for production of definitive endoderm
03/23/2011EP2297308A2 Anti-tumoral cells
03/23/2011EP2297307A1 Methods for the production of ips cells using non-viral approach
03/23/2011EP2297306A1 Human facilitating cells
03/23/2011EP2297305A2 Isolation of stem cell precursors and expansion in non-adherent conditions
03/23/2011EP2297304A1 Human bone-forming cells in the treatment of conditions and bone diseases associated with immunodeficiency or immunosuppression
03/23/2011EP2297303A2 Cell membrane engineering
03/23/2011EP2297302A1 Method of inducing proliferation and/or differentiation of neural precursor cells by introducing prolactin or wnt3a to activate latent neural precursor cells
03/23/2011EP2297300A1 Generation of induced pluripotent stem (ips) cells
03/23/2011EP2297299A1 Methods for preparing human skin substitutes from human pluripotent stem cells
03/23/2011EP2297298A2 Pancreatic endocrine progenitor cells derived from pluripotent stem cells
03/23/2011EP2297193A1 Histamine binding protein
03/23/2011EP2297185A1 Parvoviral capsid with incorporated gly-ala repeat region
03/23/2011EP2296701A1 Cell-based systems for producing influenza vaccines
03/23/2011EP2296674A2 Novel adult progenitor cell
03/23/2011EP2296672A1 Conditioned medium of liver progenitor cells
03/23/2011EP2296478A1 Brown adipocyte progenitors in human skeletal muscle
03/23/2011EP1896044B1 Bone formation composition composed of mixture of osteoblast and bio-matrix and its manufacturing method
03/23/2011EP1815001B8 Gene trap cassettes for random and targeted conditional gene inactivation
03/23/2011EP1773987B1 Stem cells obtained from pulp of deciduous or permanent teeth and of dental germ, able to produce human bone tissue